Third Wave Agbio Receives SBIR Grant | GenomeWeb

NEW YORK, Aug 29 – Third Wave Agbio said Wednesday it had received a $100,000 grant from the US Food and Drug Administration to develop DNA-based tools for detecting genetically modified organisms. 

The grant comes from the FDA’s Phase I Small Business Innovation Research program. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.